Breakthrough in Fetal Disease Study: Viable Cells in Amniotic Fluid Offer New Research Avenues
Researchers in the U.K. have made a significant discovery in fetal health research by identifying viable [...]
Major US Pharmacy Chains to Offer Abortion Pill Mifepristone
CVS and Walgreens, the two largest pharmacy chains in the United States, announced plans to dispense [...]
Pfizer’s Strategic Oncology Expansion Post-Seagen Acquisition
Pfizer aims to bolster its oncology portfolio by targeting at least eight cancer blockbuster drugs by [...]
Biden Orders to Halt Foreign Data Collection; Congress Targets Chinese Biotech
President Joe Biden issued an executive order to prevent "countries of concern," notably China and related [...]
UK Intensifies Childhood Vaccination Efforts Amid Measles Outbreak
The UK is confronting an escalating measles outbreak by launching an advertising campaign to encourage childhood [...]
Global Cholera Vaccine Shortage: A Crisis Amplified
The world faces an unprecedented cholera vaccine shortage amidst surging outbreaks across developing nations in Asia, [...]
Alabama Ruling on Frozen Embryos Raises Concerns for Cancer Patients and Fertility Treatments
The Alabama Supreme Court's recent decision to classify frozen embryos as children under the law has [...]
Johnson & Johnson Shuts Down Brisbane R&D Center Amid Strategic Shift
Johnson & Johnson (J&J) is closing its nearly 200,000 square-foot research and development (R&D) outpost in [...]
Colorado Tests State Power on Drug Pricing
Colorado’s prescription drug affordability board is considering capping the cost of Amgen’s autoimmune medication Enbrel, marking [...]
Alabama Supreme Court Ruling Redefines Embryos as Children, Impacting Fertility Treatment
In a landmark decision, the Alabama Supreme Court has ruled that embryos destroyed in a bizarre [...]
“EveryBODY Covered”: Campaign Advocates for Comprehensive Obesity Care Coverage for Women
The Alliance for Women’s Health and Prevention (AWHP) has launched the “EveryBODY Covered” campaign, with support [...]
Pharma Companies Respond to FTC Patent Challenges with Delistings
Three pharmaceutical companies—GSK, Kaléo, and Amneal—have agreed to delist several patents in response to the Federal [...]
Rick Gonzalez’s Legacy and AbbVie’s Future under Robert Michael
Rick Gonzalez, CEO of AbbVie, transformed Humira into the world's top-selling drug, defying politics and competition. [...]
Congressional Committee Threatens HHS with Compulsion Over Covid-19 Inquiry
The House Select Subcommittee on the Coronavirus Pandemic, led by Chairman Rep. Brad Wenstrup (R-Ohio), is [...]
Gilead Sciences Faces Setbacks with Magrolimab in Solid Tumor Trials
Gilead Sciences has encountered significant challenges with its anti-CD47 monoclonal antibody, magrolimab, leading to a pause [...]
Biden Administration Boosts Long Covid Research Funding by $515 Million
The Biden administration has announced a substantial increase in funding for long Covid research, adding $515 [...]
Advocacy Group Targets Congressman Over Drug Pricing Bill
Patients For Affordable Drugs Now (P4ADNow) has initiated a campaign against Rep. Don Davis (D-N.C.) through [...]
Study Reveals Long-Term Immune System Damage from Smoking
Recent research published in Nature has shed new light on the long-lasting adverse effects of smoking [...]
GSK Advances Oligonucleotide Research with Elsie Biotechnologies Platform License
GlaxoSmithKline (GSK) has solidified its commitment to oligonucleotide therapeutics by securing a nonexclusive license to Elsie [...]
Biogen CEO Optimistic Despite Financial Challenges, Eyes Growth with New Drug Launches
Chris Viehbacher, Biogen’s CEO, remains optimistic about the company’s future despite current financial difficulties. Biogen has [...]
FDA Approves Takeda’s Eohilia: A Breakthrough Oral Treatment for Eosinophilic Esophagitis
The U.S. Food and Drug Administration (FDA) recently approved Takeda's Eohilia, marking the introduction of the [...]
Study Reveals Ebola Vaccine’s Potential to Save Lives Even After Infection
A recent study has provided significant insights into the efficacy of the Ebola vaccine, particularly in [...]
Pharma CEOs Defend Drug Pricing Practices at Senate Hearing Amid Calls for Reform
CEOs from Johnson & Johnson, Merck, and Bristol Myers Squibb testified before the Senate Health, Education, [...]
Kyverna Therapeutics Raises $319 Million in IPO, Advances Autoimmune Cell Therapy Research
Kyverna Therapeutics, under CEO Peter Maag, Ph., has recently completed a $319 million Initial Public Offering [...]
Study Challenges Efficacy of High-Dose Naloxone in Opioid Overdose Survival, Raises Concerns Over Cost and Withdrawal Symptoms
A study published in the CDC's Morbidity and Mortality Weekly Report found no significant survival advantage [...]